Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3rd-line treatment

doi:10.3748/wjg.v27.i10.976

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6711)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

472

WORD

183

HTML

3206

Figures (1-3)

336

Tables (1-1)

419

Sum=4616

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

309

Download

557

Sum=866

Publishing Process of This Article

Item

Count

Browse

442

Download

787

Sum=1229

Mar 14, 2021 (publication date) through Jul 25, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Mar 14, 2021; 27(10): 976-989
Published online Mar 14, 2021. doi: 10.3748/wjg.v27.i10.976

Full Size Figure Download Figure

Figure 1 Summary of treatment predominant flow by line of therapy. SSA: Somatostatin analogues; PRRT: Peptide receptor radionuclide therapy; Liver embol: Liver embolization; HD-SSA: High-dose of somatostatin analogues.

Citation: Lamarca A, Cives M, de Mestier L, Crona J, Spada F, Öberg K, Pavel M, Alonso-Gordoa T. Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3^rd-line treatment. World J Gastroenterol 2021; 27(10): 976-989
URL: https://www.wjgnet.com/1007-9327/full/v27/i10/976.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i10.976